ARTICLE | Clinical News
Nasal Interferon alpha: Started Phase I trial
February 5, 2001 8:00 AM UTC
Nastech Pharmaceutical Co. (NSTK), Hauppauge, N.Y. Product: Nasal Interferon alpha Business: Drug delivery Therapeutic category: Immune modulation Target: Immune cells Description: Formulation of inte...